Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Creon Modernized Process vs Marketed Product in CF EPI
NCT03924947Phase 4Completed
- Sponsor
- AbbVie Inc.
- Start
- Oct 2019
- Primary completion
- Jul 2022
- Modality
- Replacement Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of pancrelipase in exocrine pancreatic insufficiency (EPI), sponsored by AbbVie Inc.. Started Oct 2019; status: completed.
02
Drugs
pancrelipase
03
Conditions
exocrine pancreatic insufficiency (EPI)
Beyond the preview
Go deeper on NCT03924947.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03924947.